US2017044102A1PendingUtilityA1
New Method for Preparing Isofagomine and Its Derivatives
Est. expiryMay 22, 2027(~0.8 yrs left)· nominal 20-yr term from priority
C07D 493/04C07D 211/46C07H 15/203A61P 43/00C07H 15/18C07D 211/42A61K 31/445Y02P20/55
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for preparing isofagomine, its derivatives, intermediates and salts thereof using novel processes to make isofagomine from D-(−)-arabinose and L-(−)-xylose.
Claims
exact text as granted — not AI-modified1 . A method for preparing isofagomine, its derivatives, or acid salts thereof, comprising:
protecting the anomeric hydroxyl group of D-(−)-arabinose with a protecting group to form a glycoside; further protecting by converting said protected glycoside to an acetonide using a ketal or ketone; converting said acetonide to an alkoxide and reacting with an alkylating agent to form an ether; converting said ether to a diol having two protecting groups; further protecting said diol using selective etherification to form a triprotected arabinose derivative; converting said arabinose derivative to a triprotected xylose derivative using an activated system; converting said xylose derivative to a triprotected nitrile using an activated system; converting said nitrile using catalytic hydrogenation.
2 - 8 . (canceled)
9 . The method of claim 1 , wherein the protecting group is selected from benzyl, methoxybenzyl, chlorobenzyl, diphenylmethyl, methyl, ethyl, isopropyl or cyclohexylmethyl.
10 . The method of claim 1 , wherein the ketone or ketal is selected from acetone, 2-butanone, benzophenone, cyclohexanone, acetophenone, or their corresponding dialkylketals.
11 . The method of claim 1 , wherein the activated system is selected from p-toluenesulfonate, methanesulfonate, and trifluoromethanesulfonate
12 . A method for preparing isofagomine, its derivatives, or acid salts thereof, comprising:
protecting the anomeric hydroxyl group of D-(−)-arabinose with a protecting group to form a glycoside having the structure of compound A:
wherein the protecting group is selected from benzyl, methoxybenzyl, chlorobenzyl, diphenylmethyl, methyl, ethyl, isopropyl or cyclohexylmethyl;
further protecting by converting said protected glycoside to an acetonide using a ketal or ketone, wherein the ketone or ketal is selected from acetone, 2-butanone, benzophenone, cyclohexanone, acetophenone, or their corresponding dialkylketals, and wherein the acetonide has the structure of compound L:
converting said acetonide to an alkoxide and reacting with an alkylating agent to form an ether, wherein the ether has the structure of compound M:
converting said ether to a diol having two protecting groups, wherein the diol has the structure of compound N:
further protecting said diol using selective etherification to form a triprotected arabinose derivative, wherein the arabinose derivative has the structure of compound O:
converting said arabinose derivative to a triprotected xylose derivative through an intermediate comprising a leaving group selected from p-toluenesulfonate, methanesulfonate, and trifluoromethanesulfonate, and wherein the xylose derivative has the structure of compound Q:
converting said xylose derivative to a triprotected nitrile through an intermediate comprising a leaving group selected from p-toluenesulfonate, methanesulfonate, and trifluoromethanesulfonate, and wherein the nitrile has the structure of compound S:
and
converting said nitrile using catalytic hydrogenation.
13 . The method of claim 12 , wherein the protecting group is benzyl.
14 . The method of claim 12 , wherein the ketone or ketal is selected from acetone, 2,2-dimethoxypropane, or combinations thereof.
15 . The method of claim 12 , wherein the leaving group is trifluoromethanesulfonate.Join the waitlist — get patent alerts
Track US2017044102A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.